Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 25;12(2):109-121.
doi: 10.5501/wjv.v12.i2.109.

Effect of SARS-CoV-2 infection on the liver

Affiliations
Review

Effect of SARS-CoV-2 infection on the liver

Adekunle Sanyaolu et al. World J Virol. .

Abstract

There have been numerous concerns about the disease and how it affects the human body since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began in December 2019. The impact of SARS-CoV-2 on the liver is being carefully investigated due to an increase in individuals with hepatitis and other liver illnesses, such as alcoholic liver disease. Additionally, the liver is involved in the metabolism of numerous drugs used to treat comorbidities and coronavirus disease 2019 (COVID-19). Determining how SARS-CoV-2 affects the liver and what factors place individuals with COVID-19 at a higher risk of developing liver problems are the two main objectives of this study. This evaluation of the literature included research from three major scientific databases. To provide an update on the current impact of COVID-19 on the liver, data was collected and relevant information was incorporated into the review. With more knowledge about the effect of the disease on the liver, better management and therapeutics can be developed, and education can ultimately save lives and reduce the long-term impact of the pandemic on our population.

Keywords: COVID-19; Coronavirus; Hepatic complications; Liver; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Effect of coronavirus disease 2019 and preexisting liver disease.
Figure 2
Figure 2
Healthy and cirrhosis liver.
Figure 3
Figure 3
Manifestations of liver damage from severe acute respiratory syndrome coronavirus 2. ALT: Alanine transaminase; AST: Aspartate transaminase; GGT: Gamma-glutamyl transferase; ALP: Alkaline phosphatase.

Similar articles

Cited by

References

    1. Ravi V, Saxena S, Panda PS. Basic virology of SARS-CoV 2. Indian J Med Microbiol. 2022;40:182–186. - PMC - PubMed
    1. Li Y, Li JZ. SARS-CoV-2 Virology. Infect Dis Clin North Am. 2022;36:251–265. - PMC - PubMed
    1. McIntosh K, Hirsch MS, Bloom A. COVID-19: Epidemiology, virology, and prevention. 16 May 2022. UpToDate. [cited 12 June 2022]. In: UpToDate.
    1. Salzberger B, Buder F, Lampl B, Ehrenstein B, Hitzenbichler F, Holzmann T, Schmidt B, Hanses F. Epidemiology of SARS-CoV-2. Infection. 2021;49:233–239. - PMC - PubMed
    1. Martinez MA, Franco S. Impact of COVID-19 in liver disease progression. Hepatol Commun . 2021;5:1138–1150. - PMC - PubMed